The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
暂无分享,去创建一个
Koji Ono | Shinji Kawabata | Hideki Matsui | Mizuki Kitamatsu | Yoshinori Sakurai | Iori Ohmori | K. Tomizawa | K. Nakajima | S. Miyatake | H. Matsui | K. Ono | Y. Sakurai | T. Nishiki | I. Ohmori | Y. Hirota | Hiroyuki Michiue | Natsuko Kondo | Feng Bin | Kiichiro Nakajima | Yuki Hirota | Tei-ichi Nishiki | Kazuhito Tomizawa | Shin-ichi Miyatake | M. Kitamatsu | H. Michiue | S. Kawabata | N. Kondo | Feng Bin | Mizuki Kitamatsu
[1] M. A. Davis,et al. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. , 1967, Journal of medicinal chemistry.
[2] L. C. Northcliffe,et al. Range and stopping-power tables for heavy ions , 1970 .
[3] K. Kanda,et al. Analytical calculation of boron- 10 dosage in cell nucleus for neutron capture therapy. , 1982, Radiation research.
[4] B. Allen,et al. Monte Carlo calculations of ion passages through brain endothelial nuclei during boron neutron capture therapy. , 1993, International journal of radiation biology.
[5] F. Szoka,et al. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. , 1993, Bioconjugate chemistry.
[6] E. Meijer,et al. Encapsulation of Guest Molecules into a Dendritic Box , 1994, Science.
[7] Natalie A. Lissy,et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration , 1998, Nature Medicine.
[8] K. Ono,et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] D. Tomalia,et al. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.
[10] H Terada,et al. A High-Efficiency Protein Transduction System Demonstrating the Role of PKA in Long-Lasting Long-Term Potentiation , 2001, The Journal of Neuroscience.
[11] T. Koga,et al. Enantioselective Binding and Stable Encapsulation of α‐Amino Acids in a Helical Poly(L‐glutamic acid)‐Shelled Dendrimer in Aqueous Solutions , 2002, Chembiochem : a European journal of chemical biology.
[12] K. Tomizawa,et al. Protein Therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery. , 2003, Current protein & peptide science.
[13] H. Yanagie,et al. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT). , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[14] Steven F Dowdy,et al. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.
[15] Ken Ohnishi,et al. Evidence for the Involvement of Double-Strand Breaks in Heat-Induced Cell Killing , 2004, Cancer Research.
[16] H. Hatanaka. A revised boron-neutron capture therapy for malignant brain tumors , 1975, Journal of Neurology.
[17] C. Tung,et al. Calculations of cellular microdosimetry parameters for alpha particles and electrons. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[18] T. Takei,et al. Synthesis and vesicle formation of a nido-carborane cluster lipid for boron neutron capture therapy. , 2004, Chemical communications.
[19] E. Snyder,et al. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids invivo , 2005 .
[20] 道上 宏之. The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction , 2005 .
[21] T. Tamiya,et al. Ubiquitination‐resistant p53 protein transduction therapy facilitates anti‐cancer effect on the growth of human malignant glioma cells , 2005, FEBS letters.
[22] M. Vicente,et al. Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects , 2005, Clinical Cancer Research.
[23] E. Snyder,et al. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. , 2005, Expert opinion on drug delivery.
[24] Daniel J Brat,et al. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. , 2005, Neuro-oncology.
[25] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[26] J. Hardy,et al. Dendrons with spermine surface groups as potential building blocks for nonviral vectors in gene therapy. , 2006, Bioconjugate chemistry.
[27] K. Ono,et al. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy. , 2006, International journal of radiation oncology, biology, physics.
[28] S. Dowdy,et al. TAT transduction: the molecular mechanism and therapeutic prospects. , 2007, Trends in molecular medicine.
[29] S. Miyatake,et al. BORON NEUTRON CAPTURE THERAPY FOR MALIGNANT TUMORS RELATED TO MENINGIOMAS , 2007, Neurosurgery.
[30] Takashi Nakajima,et al. Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer: A Clinicopathologic Study , 2007, Clinical Cancer Research.
[31] Y. Lim,et al. Controlled bioactive nanostructures from self-assembly of peptide building blocks. , 2007, Angewandte Chemie.
[32] Kit S Lam,et al. From combinatorial chemistry to cancer-targeting peptides. , 2007, Molecular pharmaceutics.
[33] Hiroyuki Nakamura,et al. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy. , 2007, Organic letters.
[34] T. Niidome,et al. Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[35] L. Salford,et al. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[36] A. Detta,et al. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. , 2009, Cancer research.
[37] R. Barth. Boron neutron capture therapy at the crossroads: challenges and opportunities. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[38] M. Scadeng,et al. Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma , 2009, Cancer biology & therapy.
[39] A. Matsumura,et al. Boron neutron capture therapy for newly diagnosed glioblastoma. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] K. Tomizawa,et al. Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His. , 2009, Biomaterials.
[41] K. Tomizawa,et al. Development of a bifunctional immunoliposome system for combined drug delivery and imaging in vivo. , 2010, Biomaterials.
[42] M. Matsushita,et al. Recent Advances in Protein Transduction Technology , 2010, Cell transplantation.
[43] Y. Kanai,et al. l‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth , 2010, Cancer science.
[44] S. Dowdy,et al. Protein transduction domain delivery of therapeutic macromolecules. , 2011, Current opinion in biotechnology.
[45] D. Engelman,et al. pHLIP peptide targets nanogold particles to tumors , 2012, Proceedings of the National Academy of Sciences.
[46] H. Ban,et al. Design and synthesis of fluorescence-labeled closo-dodecaborate lipid: its liposome formation and in vivo imaging targeting of tumors for boron neutron capture therapy. , 2012, Organic & biomolecular chemistry.
[47] T. Ohtsuki,et al. Synthesis and properties of peptide dendrimers containing fluorescent and branched amino acids. , 2013, Biopolymers.